Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Lymphoma

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Lymphoma in 1 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Honeysett, JM1
Insel, PA1

Other Studies

1 other study available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Lymphoma

ArticleYear
Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Journal of cyclic nucleotide research, 1981, Volume: 7, Issue:5

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosylmethionine Decarboxylase; Alprostadil; Bucla

1981